Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 22857753)

1.

Editorial comment.

Meng MV.

Urology. 2012 Aug;80(2):359; author reply 359-60. doi: 10.1016/j.urology.2012.03.068. No abstract available.

PMID:
22857753
2.

Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences?

Karaolides T, Skolarikos A, Bourdoumis A, Konandreas A, Mygdalis V, Thanos A, Deliveliotis C.

Urology. 2012 Aug;80(2):354-9. doi: 10.1016/j.urology.2012.03.067.

PMID:
22857752
3.

Editorial comment.

Scarpa RM, Cracco CM.

Urology. 2009 Dec;74(6):1286-7; author reply 1287-8. doi: 10.1016/j.urology.2009.08.033. No abstract available.

PMID:
19962530
4.

Editorial comment.

Sagalowsky AI.

J Urol. 2012 Jul;188(1):62. doi: 10.1016/j.juro.2012.03.134. Epub 2012 May 12. No abstract available.

PMID:
22583634
5.

HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study.

Geavlete B, Jecu M, Multescu R, Georgescu D, Geavlete P.

Urology. 2010 Sep;76(3):664-9. doi: 10.1016/j.urology.2010.02.067. Epub 2010 Jun 8.

PMID:
20627289
6.

Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies.

Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, Jocham D, Ziegler A, Vonthein R.

Eur Urol. 2010 Apr;57(4):595-606. doi: 10.1016/j.eururo.2009.11.041. Epub 2009 Dec 2. Review.

PMID:
20004052
7.

New bladder cancer removal technique reduces recurrence.

[No authors listed]

Mayo Clin Health Lett. 2010 Feb;28(2):4. No abstract available.

PMID:
20333825
8.

Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.

Witjes JA, Redorta JP, Jacqmin D, Sofras F, Malmström PU, Riedl C, Jocham D, Conti G, Montorsi F, Arentsen HC, Zaak D, Mostafid AH, Babjuk M.

Eur Urol. 2010 Apr;57(4):607-14. doi: 10.1016/j.eururo.2010.01.025. Epub 2010 Jan 22. Review.

PMID:
20116164
9.

Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.

Burger M, Stief CG, Zaak D, Stenzl A, Wieland WF, Jocham D, Otto W, Denzinger S.

Urology. 2009 Dec;74(6):1282-6. doi: 10.1016/j.urology.2009.06.088. Epub 2009 Oct 12.

PMID:
19819538
10.

[Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer].

Danil'chenko DI, Koenig F, Riedl K, Schnorr D, Waldman A, Al-Shukri S, Loening SA.

Vopr Onkol. 2003;49(6):734-7. Russian.

PMID:
14976918
11.

Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid.

Drăgoescu O, Tomescu P, Pănuş A, Enache M, Maria C, Stoica L, Pleşea IE.

Rom J Morphol Embryol. 2011;52(1):123-7.

12.

[Comment to "Photodynamic diagnosis with hexaminolevulinate in Non-Muscle-Invasive Bladder Cancer. Experience of the BLUE GROUP"].

Burger M.

Actas Urol Esp. 2011 Sep;35(8):446-7. doi: 10.1016/j.acuro.2011.04.006. Epub 2011 Jun 11. Spanish. No abstract available.

PMID:
21658814
15.

Editorial: Bladder cancer. How can we make a difference?

Soloway MS.

J Urol. 2003 Nov;170(5):1781-2. No abstract available.

PMID:
14532775
16.

Editorial comment.

Rodriguez AR.

Urology. 2010 Jun;75(6):1390-1; author reply 1391. doi: 10.1016/j.urology.2009.11.026. No abstract available.

PMID:
20513498
17.

Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.

Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, Loening SA, Schnorr D.

J Urol. 2005 Dec;174(6):2129-33, discussion 2133.

PMID:
16280742
18.

Editorial comment.

Nix J, Pruthi RS.

J Urol. 2010 Jan;183(1):86; discussion 86. doi: 10.1016/j.juro.2009.08.214. Epub . No abstract available.

PMID:
19913811
19.

Blue-sky thinking about blue-light cystoscopy.

Thomas K, O'Brien T.

BJU Int. 2009 Oct;104(7):887-9. doi: 10.1111/j.1464-410X.2009.08713.x. Epub 2009 Jul 2. No abstract available.

PMID:
19583718
20.

[Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].

Matveev BP, Kudashev BV, Bukharkin BV, Romanov VA, Rubanov IuV.

Urologiia. 2000 May-Jun;(3):22-4. Russian.

PMID:
11186703
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk